SEARCH
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place to Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
FORTUNE 500
FORTUNE 500
FORTUNE SEA 500
Fortune 500 Europe
Fortune Global 500
Fortune China 500
Great Place to Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Banking
Investing
Crypto
Leadership
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
Johnson & Johnson
Johnson & Johnson
Page 13 of 18
Johnson & Johnson Accused of Dodging Liability for Its Alleged Role in Opioid Epidemic
By
Jef Feeley
and
Bloomberg
July 15, 2019
Health
Johnson & Johnson to Test a Pioneering HIV Vaccine: Brainstorm Health
By
Sy Mukherjee
July 12, 2019
Leadership
J&J CEO’s West Point Lesson: Great Leaders Know How to Listen
By
Susie Gharib
April 17, 2019
Xarelto to Become First Prescription Drug With TV Ads That Includes Pricing
By
Erik Sherman
March 29, 2019
Jury Awards $29 Million in Latest Johnson & Johnson Cancer-Causing Baby Powder Lawsuit
By
Brittany Shoot
March 15, 2019
Finance
Mithril Capital’s Ajay Royan Talks About Working with Peter Thiel and Why ‘Investing Is Hard’
By
Rey Mashayekhi
February 28, 2019
Johnson & Johnson Will Be The First Drug Company To Put Prescription Medication Prices in TV Ads
By
Laura Stampler
February 8, 2019
Johnson & Johnson’s Slowdown Signals a Warning to Health Care Sector
By
Bloomberg
January 22, 2019
Health
Johnson & Johnson’s $50 Billion Baby Powder Problem Just Got a Whole Lot Worse. Here’s Why
By
Lucas Laursen
December 19, 2018
Glaxo to Split in Two Following Venture Deal with Pfizer
By
Bloomberg
December 19, 2018
Leadership
Companies Strike Back, Moonves Fired, China: CEO Daily for December 18, 2018
By
Lucas Laursen
and
Alan Murray
December 18, 2018
Health
Johnson & Johnson Knew Baby Powder Contained Asbestos for Decades, Report Claims
By
Chris Morris
December 14, 2018
Leadership
Johnson & Johnson CEO Says Fix the Drug Pricing Process, But Not Too Much
By
Susie Gharib
December 4, 2018
Advertisers Are Giving People With 1,000 Instagram Followers Endorsement Deals
By
Laura Stampler
November 13, 2018
Commentary
What Pharma Giant Johnson & Johnson’s CEO Has to Say About the Drug Price Debate
By
Sy Mukherjee
October 18, 2018
Most Popular
Commentary
My wife sold her engagement ring to pay our tax bill. It led to my PhD and my career tackling the student-debt crisis
By
Brian Walsh
Success
AI expert says it’s ‘not a question’ that AI will take over all jobs—but people will have 80 hours a week of free time
By
Emma Burleigh
Success
Workday’s CEO says his career took off after he changed his attitude—and Amazon boss Andy Jassy swears by the same...
By
Preston Fore